NEW YORK (GenomeWeb News) – Eurofins MWG Operon has been certified to provide Roche NimbleGen's sequence capture technology coupled with Roche 454 Life Sciences sequencing in Europe.
Eurofins said on Tuesday that it has become a certified service provider for the NimbleGen Titanium Optimized Sequence Capture technology, making it the first certified provider for the technology in Europe.
Ebersberg, Germany-based Eurofins will process DNA samples for genomic enrichment using the NimbleGen workflow, which has been optimized for 454 Titanium sequencing using 385K arrays, Roche said.
Bruno Poddevin, Eurofins' head of Genomic Services, said in a statement that the Sequence Capture technology "contributes significant speed and an optimized workflow to support our position as a leading provider of state-of the art services to our customers."